Gene Therapy calls for papers / meetings & conferences

Call for Abstracts: American Society of Human Genetics 62nd Annual Meeting

Tuesday, November 6 through Saturday, November 10, 2012 San Francisco, California

The receipt deadline for new abstract submission is June 4, 2012 at 8:00 pm (US EDT).

The world's top scientists and clinicians in the human genetics field will gather to present their latest research findings at the 62nd Annual Meeting of the American Society of Human Genetics (ASHG), which will be held on November 6-10, 2012, in San Francisco, CA (http://www.ashg.org/2012meeting). ASHG is the primary professional membership organization for human genetics specialists worldwide, representing nearly 8,000 researchers, academicians, clinicians, genetic counselors, nurses, and others with a special interest in this area (http://www.ashg.org).

The ASHG Annual Meeting continues to be the largest human genetics meeting in the world, attracting more than 7,000 scientific participants each year. The ASHG 2012 Meeting will provide attendees with the latest information about cutting-edge developments in human genetics and genomics research. In addition, nearly 250 U.S. and international exhibitors at this year's ASHG Exhibitor Trade Show will offer an unprecedented opportunity to view the latest advances in genetics-related products and services derived, in part, from work presented at previous ASHG meetings.

Topics to be addressed in the scientific program for the ASHG 2012 Meeting will include: gene discovery in human genetics; new insights and challenges from next generation sequencing; advances in medical genetics and translation/applications in clinical care; progress in gene therapy; personalized medicine; cancer genetics; advances in non-invasive prenatal diagnosis; revelations about human alleles from studies of model organisms; implications of population genetic studies; modeling in statistical genetics; data centralization and its implications for our field; ethical, legal and social implications of genomics; changes in genetics education; and much more.

For more information about the ASHG 2012 Annual Meeting, or to register and/or submit an abstract for presentation at this year’s meeting, please go to: http://www.ashg.org/2012meeting.

Call for Abstracts: 3rd Annual International Conference on Advances in Biotechnology (BioTech 2013)

18 - 19 March 2013 Singapore

Paper Submission (Full Paper) Deadline 28 September 2012

Biotechnology is a field of applied biology that involves the use of living organisms and bioprocesses in engineering, technology, medicine and other fields requiring bioproducts. The concept encompasses a wide range of procedures for modifying living organisms according to human purposes - going back to domestication of animals, cultivation of plants, and "improvements" to these through breeding programs that employ artificial selection and hybridization.

This multi-disciplinary conference aims to provide a challenging forum and vibrant opportunity for researchers and industry practitioners to share their original research results and practical development experiences on specific new challenges and emerging issues.

Topics of interest include, but are not limited to:

Pharmaceutical / Medicine

• Structural Biology
• Proteomics
• Cell Cycle and Oncology
• Medical Microbiology
• Diagnostic Pathology
• Clinical Chemistry
• Haematology
• Diagnostic Imaging
• Medical Imaging and Methods
• Sonography
• Molecular and Cell Biology
• Biochemistry
• Immunology
• Genetics
• Neurobiology
• Drug production
• Pharmacogenomics
• Gene therapy
• Factors for transcribing DNA into RNA
• Monoclonol antibodies
• Pathogenesis of Human Diseases
• Presymptomatic testing

Food and Agriculture

• Genetic engineering
• Genomics
• Tissue culture
• Cell fusion
• Molecular biology
• Enzymology
• Fermentation processes
• Instrumentation and diagnostic methods
• Food processing
• Biofertilizer
• Waste Technology
• Environment Control
• Pest and diseases resistant crop
• High value addictives and chemical products
• Immunological techniques
• Signal transduction
• Conjugation
• Classical mutagenesis
• Conjugation process
• Hybridisation

Best Paper Award

A number of best papers will be selected and given awards at the conference. These papers will also be considered for publication in GSTF and other international refereed Journals.

In order to qualify for the award, at least one of the authors will need to present at the conference.

CONFERENCE SECRETARIAT 

Global Science & Technology Forum (GSTF)
10 Anson Road, International Plaza,
Singapore 079903
DID : +65 6327 0166
Fax : +65 6327 0162 

For Conference Information info@advbiotech.org 
For Registration, Accommodation or Visa Assistance secretariat@advbiotech.org  

Call for Abstracts: 24th Annual Fanconi Anemia Research Fund Scientific Symposium

September 27 – 30, 2012 Denver, Colorado

Session topics may include:

Bone marrow failure and transplantation
Gene therapy and stem cell expansion
Functions of FA proteins
Role of environmental and endogenous mutagens
Small molecule development and therapeutics
Other experimental therapies
Squamous cell carcinoma and HPV
Other cancers in FA
Molecular pathogenesis and control of hematopoietic and epithelial neoplasms
Pathophysiology and treatment of endocrinopathies

Abstracts may be submitted from May 29 to June 28, 2012 at www.fanconi.org. The submission site will open at 9:00 am Pacific Time on May 29 and close at 9:00 am Pacific Time on June 28. The Fund’s abstract review committee will select abstracts for oral and poster presentations based on scientific merit. Please see complete abstract submission guidelines.

Note: There will be no late-breaking abstracts submission period.

Attendance: Presenters are expected to attend for the duration of the symposium, including the closing Symposium Town Hall: An Interactive Discussion about FA Research on September 30.

Call for Abstracts: International Symposium on Ocular Pharmacology and Therapeutics ISOPT Clinical 2013

March 7-10, 2013 Paris, France

The deadline for the submission of abstracts: December 4th, 2012.

Abstracts submitted after this deadline may be considered for presentation, but will not be included in the program book.

ISOPT will reconvene in Paris March 7 – 10 for our 10th symposium. Over the years, ISOPT has repeatedly shaped its form so it can accommodate to provide a collaborative atmosphere for clinicians, clinical trialists, pharma industry and regulatory officers. Our formed vision has been to increase knowledge and awareness of drug usage in ophthalmology reflecting innovations and their utilization in practice. In order to achieve this vision ISOPT is set to implement the following missions:

Educate via updating and sharing current and evolving treatment algorithms for practitioners.

Connect data arising from clinical studies to actual daily practice.

Facilitate innovation via panels and discussions of early and late “development related topics”.

We invite you to join us in Paris, and become a part of ISOPT, bring your own experience and insights of treating your patients, be exposed to the last two year clinical experience gained in major industry supported studies and be part of the efforts to reflect scientific data to clinical reality and patient care.

ISOPT has become famous for its informal atmosphere and the ability to meet experts and faculty leaders for “out of the lecture hall” discussions.

Whether your field of interest is in retinal diseases, inflammation, cornea and external diseases, glaucoma or basic science you may contribute and be part of the ISOPT spirit.